Leukotriene C4 modulation of muscarinic K+ current activation in bullfrog atrial myocytes by unknown
Leukotriene  C 4  Modulation of Muscarinic 
K + Current Activation in Bullfrog 
Atrial Myocytes 
ROBERTA  W.  SCHERER,  C.  FREDERICK  Lo,  and  GERDA  E.  BREITWIESER 
From the Department of Physiology, Johns Hopkins University, School of Medicine, 
Baltimore, Maryland 21205 
ABSTRACT  The  effects  of  leukotriene  C4  (LTC4)  on  activation  of muscarinic 
acetylcholine receptor (mAChR)-stimulated,  inwardly rectifying K + current (I~Achl) 
were examined  in single bullfrog atrial myocytes using the whole-cell patch clamp 
technique.  LTC4  produced  a  reversible,  concentration-dependent  increase  in 
steady-state,  guanosine--y-thiotriphosphate  (GTP~tS)-activated IKt^Chl, with a  K0.5 of 
3.1  IzM. LTC4 also increased the rate of GTP~/S-mediated IKIAChl  activation, both in 
the  absence  and  presence  of 1  nM  ACh,  with  comparable  K0.5 values  of 4.7  izM 
under basal conditions and 4.9 IzM in the presence of 1 nM ACh. LTC4 did not alter 
the relative affinities of the G protein, Gk, for GTP~/S and GTP. We hypothesize that 
all  of the  effects  of LTC4  on  the  kinetics  of Gk-mediated  IKtACh] activation  are 
produced  at a  common site with a  K0.5 of 3-5  I~M. The effects of LTC4 on IKtACh] 
activation  are  fully  reversible  in  the  presence  of  GTP,IS.  Under  physiological 
conditions  (i.e., intracellular  GTP),  10 izM LTC4 increased the ACh-activated peak 
Ir4AChl. Inhibitors of cellular LTC4 production,  including  5,8,11,14-eicosatetraynoic 
acid, baicalein, cinnamyl-3,47dihydroxy-a-cyanocinnamate , and a-pentyl-4-(2-quino- 
linylmethoxy)-benzene  methanol,  greatly attenuated ACh-dependent  IrqAChl activa- 
tion, preventing activation of peak, and producing a lower steady-state IKIAChl  (when 
compared with the control response in the same cell). Addition of exogenous LTC4 
was able  to overcome the  effects of LTC4 synthesis  inhibitors,  restoring  both  the 
peak and steady-state Iv4AChl responses. Although the mechanism of LTC4-mediated 
modulation of IKtACnl activation is not known, our results suggest that endogenously 
produced  lipoxygenase  metabolites  of  arachidonic  acid,  specifically  LTC4,  are 
involved in the physiological process of I~lAChl activation. 
INTRODUCTION 
Acetylcholine  (ACh)  binding  to atrial muscarinic receptors  (mAChR)  induces  activa- 
tion of an inwardly rectifying potassium current,  IK[ACh]. A pertussis toxin-sensitive G 
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protein,  Gk,  couples mAChR  to  the  K[ACh] channel.  A  variety of arachidonic  acid 
metabolites, including leukotrienes, induce IK[ACh] activity at the single channel level 
(Kim, Lewis, Graziadei, Neer, Bar-Sagi, and Clapham,  1989; Kurachi, Ito, Sugimoto, 
Shimizu,  Miki,  and  Ui,  1989).  Receptor-mediated  arachidonic  acid  liberation  and 
subsequent metabolism via the 5-1ipoxygenase pathway has been implicated in the 
activation OflK[ACh]  via both ~-adrenergic (Kurachi, Ito, Sugimoto, Shimizu, Miki, and 
Ui,  1991) and platelet activating factor receptors (Nakajima, Sugimoto, and Kurachi, 
1991) in mammalian atrial myocytes. It has been suggested that mAChR-mediated 
release of arachidonic acid occurs via direct ~/subunit activation of phospholipase A2 
(PLA2; Kim et al.,  1989; Clapham,  1990), although more recent experiments suggest 
that  [3~/ subunits  are  able  to  activate  the  K[ACh] channel  despite  the  presence  of 
inhibitors  of arachidonic  acid  release  and/or  metabolism  (Ito,  Tung,  Sugimoto, 
Kobayashi, Takahashi,  Katada, Ui, and Kurachi,  1992). 
Both lipoxygenase and  cyclooxygenase metabolites of arachidonic acid modulate 
whole-cell IK[AChl (Scherer and Breitwieser,  1990), with the most pronounced stimu- 
latory effect produced  by  the  leukotriene  LTC4.  LTC4  increases  both  the  rate  of 
guanosine-~/-thiotriphosphate  (GTP~/S)-mediated  activation  of  IK[ACh] and  the 
GTP,/S-mediated rate of IKtACh] activation in the presence of low concentrations (1-10 
nM) of ACh, suggesting that its effects are additive with those of muscarinic agonists. 
The magnitude of steady-state IK[AChl (60 S after ACh application, following densen- 
sitization of peak current) is  slightly increased by  10  ~M  LTC4 in the presence of 
nordihydroguaiaretic acid (NDGA, a 5- and  12-1ipoxygenase inhibitor)when Gk was 
persistently  activated  by  GTP~/S  (Scherer  and  Breitwieser,  1990),  suggesting  the 
possibility that some of the effects of LTC4 can be localized to either GTP~/S-activated 
Gk,  the  muscarinic  K ÷  channel  itself,  or  their  interaction  (since  mAChR  was 
uncoupled from the pathway). 
In  this  report, we  explore  more  fully  the  role  of LTC4  in IK[AChl activation,  to 
determine  whether  the  effects  are  relevant  to  the  physiological  mechanism  of 
mAChR-mediated  K[ACh] channel activation. We find that all of the LTC4-mediated 
effects are half-maximal at 3-5 ~M, and that both the rate of Gk activation and the 
magnitude  of GTP~/S-activated  steady-state  IK[ACh] are  enhanced  by  LTC4.  Since 
blockers of LTC4 biosynthesis decrease the magnitude of ACh-stimulated IK[ACh], we 
suggest that the presence of LTC4 is required for maximal mAChR-mediated IK[ACh] 
activation. 
METHODS 
Cell Preparation 
Dissociated atrial myocytes were obtained from the bullfrog Rana catesbeiana with a collagenase/ 
trypsin perfusion procedure as previously described (Scherer and Breitwieser, 1990). The heart 
was removed, rinsed in HEPES-buffered Ringers solution, and perfused with Ca~+-free Ringers 
solution  (mM): 88.4 NaCI, 2.5 KCt, 1.8 MgCI2, 23.8 NaHCO3, 0.6 NaH2PO4, 2.5 pyruvate,  1 
mg/ml fatty acid-free bovine serum albumin,  and MEM vitamins and essential amino acids (1 
pMml, 100X stock; Sigma Chemical Co., St. Louis, MO), equilibrated with 5% CO2 at 28°C. The 
heart was then perfused for 60 rain with a recirculating dissociating solution (25 ml of Ca2+-free 
Ringers  containing 5 mM creatine, 50  U/ml penicillin,  50  ~,g/ml streptomycin,  0.4 mg/ml 
trypsin  (Boehringer Mannheim Corp.,  Indianapolis,  IN),  and 2.3-2.5 mg/ml collagenase  B SCHERER ET AL.  Leukotriene C4 Modulation  of Muscarinic K + Current Activation  127 
(Clostridium  histolyticum;  Boehringer  Mannheim  Corp.).  Myocytes  were  released  from  the 
dissected atria by agitation and diluted twofold with Ca2+-free Ringers plus 0.9 mM CaCI2, 5 
mM  glucose,  1 ~l/ml MEM vitamins and  essential amino acids, 50  U/ml penicillin, and  50 
~.g/ml streptomycin, and stored in suspension at room temperature until use (within 6-8 h). 
Solutions 
Bath solution (HEPES-buffered Ringers solution) contained (raM): 90 NaCI, 2.5 KCI, 5 MgCI~, 
2.5 CaCI2, and 20 HEPES, pH 7.4. To block Ca  ~+ and Na  + currents, 500 p.M CdCI2 and 5 ~M 
tetrodotoxin were  added,  respectively. The  intracellular solution  contained  (raM):  80  K + 
aspartate, 30 KC1, 1 EGTA, 0.05  Na2GTP,  5 MgATP, and 5 HEPES,  pH 7.4. When present, 
GTP,/S  (1  raM) was added as the  Li salt. Stock solutions of 5,8,11,14-eicosatetraynoic acid 
(ETYA;  Calbiochem-Novabiochem Corp.,  La Jolla, CA or Cayman Chemical Co.,  Inc., Ann 
Arbor, MI), 5,6,7-trihydroxyflavone (baicalein; BIOMOL Research Labs Inc., Plymouth Meet- 
ing, PA), cinnamyl-3,4-dihydroxy-a-cyanocinnamate  (CDC; BIOMOL Research Labs Inc.), and 
ct-pentyl-4-(2-quinolinylmethoxy)-benzenemethanol  (L-655,238; BIOMOL Research Labs Inc.) 
in ethanol, or leukotrienes C4 (glycine, N-[S-[1-(4-carboxy-l-hydroxybutyl)-2,4,6,9-pentadeca- 
tetraenyl]-N-L-'y-glutamyl-L-cysteinyl]-, [R-[R*,S*-(E,E,Z,Z)]]),  B4  (6,8,10,14-eicosatetraenoic 
acid, 5,12-dihydroxy-, [S-[R*,S*-(E,Z,E,Z)]]),  or D4 (glycine, N-[S-[l-(4-carboxy-l-hydroxylbu- 
tyl)-l,4,6,9-pentadecatetraenyl-e-cysteinyl]-[R-[R*,S*-(E,E,Z,Z)]])  (Cayman Chemical Co., Inc.) 
in either ethanol or 50:50 PBS/ethanol were stored at -80°C.  Ethanol concentrations in the 
final extraceUular solutions did not exceed 3%, and were without effect in control experiments. 
Electrophysiology 
Whole-cell  patch  clamp  (Hamill,  Marty,  Neher,  Sakmann,  and  Sigworth,  1981)  of atrial 
myocytes was  performed,  with  minor  modifications,  as  previously described  (Scherer  and 
Breitwieser, 1990).  Electrodes were fabricated of square bore glass (1.0 mm o.d.; Glass Co. of 
America,  Millville, NJ)  on  a  Flaming  Brown  micropipette  puller  (Sutter  Instrument  Co., 
Novato, CA) and were used without fire-polishing. Tip potentials were corrected, but junction 
potentials were not. Voltage clamp protocols were generated with a computer-driven arbitrary 
waveform generator (model 75; Wavetek, San Diego, CA),  or with PClamp software (version 
5.5.1;  Axon Instruments,  Inc.,  Foster City, CA).  The  protocol for monitoring /K[ACh] utilized 
sequential 250-ms voltage steps to -90, -  125, and -5 mV from a holding potential of -85 mV 
(with return to the holding potential between steps). Steady-state current-voltage relationships 
were determined by assessing the average current at the end of 250-ms voltage steps to various 
potentials. Pulse protocols were applied to the cell continuously from the moment of patch 
rupture. A 5-mV hyperpolarizing pulse from the holding potential was included in all protocols 
to allow continuous monitoring of the pipette series resistance, which was not electronically 
compensated  (this  procedure  provides a  measure  of the  access of pipette  solutions to  the 
interior of the cell; Breitwieser and Szabo,  1988).  Currents were measured with a  List EPC-7 
patch clamp amplifier (List, Darmstadt-Eberstadt, Germany) and monitored with a model 310 
oscilloscope (Nicolet Instrument  Corp.,  Madison, WI). Signals were  digitized with a  PCM-1 
instrumentation  adaptor (Medical Systems Corp.,  Greenvale, NY)  and  stored on VCR  tape. 
Rates  of IK~ACh] activation were  estimated by recording  the  analog  signal  on  an  Astromed 
recorder (model Z100; Astro-Med, Inc., West Warwick, RI) or by linear fits to digitized PClamp 
files. Data are reported as mean +_ SEM. Dose-response relationships to the equations noted in 
the  text  were  fit  by  least-squares  minimization  using  the  Marquardt-Levenberg  algorithm 
(NFIT; Island Products, Galveston, TX). All experiments were performed at room temperature 
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RESULTS 
Effect of LTC4 on GTPyS-activated Steady-State  IKfAChl 
A variety of arachidonic acid metabolites, including leukotrienes, modulate activation 
of the muscarinic K + current, IKIAChl, in atrial myocytes (Kim et al.,  1989; Kurachi et 
al., 1989; Scherer and Breitwieser, 1990). In particular, LTC4 (10 p.M in the presence 
of 10 p.M NDGA, a 5- and  12-1ipoxygenase inhibitor), produces a  slight increase in 
steady-state,  GTP~/S-activated IK{AChl (Scherer and  Breitwieser,  1990).  Because  the 
LTC4-mediated increase  in  steady-state GTP~/S-activated IK[AChl may result from a 
novel regulatory  mechanism,  we  examined  the  properties  of this  effect of LTC4. 
Pipette solutions contained  1 mM GTP~/S. A brief pulse of 1 p.M ACh was used to 
activate peak IK[ACh], which declined  to  steady-state IK[ACh] (IK[AChlss), and  persisted 
despite  removal  of ACh  from  the  bath  solution,  as  is  illustrated  for  the  control 
experiment  in  Fig.  1 A.  Illustrated  in  Fig.  1, B  and  C,  are  the  effects  of bath 
application of 1 and  10  I~M LTC4, respectively, on GTP~S-activated IK[ACh]ss- LTC4 
reversibly elicits additional current, which is not affected by  10  tLM atropine, but is 
blocked by 0.5 mM Ba  2+  (data not shown). The current-voltage relationship of the 
LTC4-elicited  current  is  qualitatively  similar  to  the  steady-state  current-voltage 
relationship  of IK[ACh] in  the  same  cell (Fig.  1 D,  relationships  plotted for the  cell 
illustrated in Fig.  1 C at the times denoted by the various symbols), suggesting that 
LTC4 increases IK[ACh] rather than activating a distinct K + current. This interpretation 
is further supported by the fact that LTC4 has been shown to activate K[ACh  ] channels 
in cell-attached and excised patches (Kim et al.,  1989; Kurachi et al.,  1989; Clapham, 
1990). 
The LTC4-mediated increase in IK[ACh]ss occurs rapidly, and upon removal of LTC4 
the current rapidly returns to the control level of GTP~/S-mediated steady-state IK[ACh] 
(Fig. 1, B and C). The reversibility of this effect suggests that LTC4 does not act via a 
G  protein--coupled receptor (which would mediate a  persistent increase in /K[ACh]ss 
under  these  experimental conditions). The  increase  in IKIAChl induced by LTC4 is 
saturable (Fig. 2). The line through the data points represents the fit to a single site 
model, with  a  K0.5 of 3.1  p.M. The  LTC4-mediated increase  in IK[ACh] saturates  at 
155%  of  the  control,  GTP~/S-activated  IK[ACh]ss. Comparison  of  the  increase  in 
steady-state IK[ACh] achieved by l0 IxM LTC4 (143 --- 22% of control IK[AChlss, n  =  10), 
10 p.M LTB4 (109 -+  11% of control IK[AChlss, n  =  5), and 10 p.M LTD4 (109 -  25% of 
control  IK[ACh]ss, n  =  5)  suggests  specificity  for  the  structure  of LTC4.  Neither  a 
lipophilic analogue (LTB4) nor an analogue with a truncated peptidyl group (LTD4) 
is able to mimic the LTC4 effect. 
ETYA, which inhibits both cyclooxygenases and lipoxygenases (Tobias and Hamil- 
ton,  1979;  Bokoch and  Reed,  1981),  has  no effect on GTP~/S-activated IK[ACh]ss at 
concentrations as  high  as  10  IxM. Fig.  3  illustrates  a  typical experiment,  in which 
IK[AChl was first persistently activated in the presence of GTP~/S, and then ETYA (10 
p.M) was applied. The lack of ETYA effect on GTP~S-activated IK[AChlss suggests that 
cellular production of LTC4 does not contribute significantly to the maintenance of 
GTP~/S-activated IK[ACh]ss. This result is not specific to ETYA, since other inhibitors of 
LTC4  synthesis  such  as  baicalein  (a  lipoxygenase  and  leukotriene  biosynthesis 
inhibitor;  Sekiya  and  Okuda,  1982;  Kimura,  Okuda,  and  Arichi,  1987),  and SCHERER ET AL.  Leukotriene C4 Modulation of  Muscarinic K + Current Activation  129 
L-655,238  (a  5-1ipoxygenase  activating  protein  [FLAP]  inhibitor;  Evans,  Leveille, 
Mancini,  Prasit,  Therien,  Zamboni,  Gauthier,  Fortin,  Charleson,  Macintyre  et  al., 
1991)  also  have  no  effect  on  GTP~/S-activated  steady-state  IK[ACh]- ETYA  does, 
however,  modulate  the  GTP~/S-mediated  rate  of IIqAChl activation  (all experiments 
done  with  a  pipette  solution  containing  1  mM  GTP~/S  and  50  ~M  GTP):  control, 
0.27  +  0.01  min -1  (n =  6);  1  IzM ETYA,  0.16  --- 0.01  rain -1  (n =  7),  suggesting an 
150 
> 
F=  100 
'9, 
~  so 
A  ACh 
2  4 
> 
E 
u?, 
200 
C 
150 
100 
SO 
0 
10 pM LTC 4 
ACh  n 
6  2  4 
time (mln)  time (rain) 
150 
> 
E  ioo  l.O 
<  so 
0 
ACh  1 pM LTC  4 
,  ,~fl  S  ,  i 
2  4 
<= 
g 
8 
o  g~ 
go 
~n 
O 
200 
oi  ° 
-200 
-400 
-600 
-800 
-1000 
-150  -t00 
i  i 
0  6  -50  0  50 
time (rain)  mV 
FIGURE  1.  Effect of LTC 4  on  GTP~/S-activated IK[ACh]ss" IK[ACh]  was activated in the presence of 
I mM GTP~S and 0.05 mM GTP. A brief (10-15 s) exposure to 1 o.M ACh was used to induce 
rapid, irreversible activation of IV4AChV Plotted in A-C are the time-dependent changes in the 
averaged magnitude of outward current at  -5 mV at the end of 250-ms voltage steps from a 
holding potential of -85 InV. (A) Washout of ACh under control conditions results in stable 
Iv4Achls~. (B) After washout ofACh,  1 IrM LTC4 was added to the superfusing Ringers solution, 
resulting in an increase in outward current. Washout of LTC4 resulted in a return to the control 
level of Iv4Achl~s. (C) Same protocol as described in B, with  10 v.M LTC4.  (D) Current-voltage 
relationships for the experiment illustrated in C, taken at the times indicated by the symbols: 
27, before activation of/KtACh]; El, GTP~/S-activated ]giACh]ss  in the presence of 10 v.M LTC4;  ~, 
GTP~/S-activated l~AchJss- The  cell was  held  at  -85  mV  and  stepped  to  the  various  test 
potentials for 250 ms. Average current at the end of each pulse is plotted. 
involvement of endogenous  lipid metabolites during activation. The effect of ETYA 
on  the  GTP~S-mediated  rate  of IK[ACh] activation  is  overcome  by  LTC4:  ]  v.M 
ETYA +  10 I~M LTC4,  0.46  +  0.03  min -l (n =  3), which is significantly higher than 
the control rate, and almost the same as the rate obtained in the presence of 10 lxM 
LTC4  alone,  0.53  +  0.05  rain -1  (n =  4).  The  absence  of an  effect  of ETYA  on 
steady-state GTP~S-activated IK[ACh] and  the  attenuation  by  ETYA  of the  GTP',/S- 130 
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FIGURE 2.  Dose response for LTC4- 
mediated increase in GTPTS-activated 
IV4ACh],. Experiments were performed 
as illustrated in Fig. 1, B and C. Plot- 
ted versus the LTC4 concentration in 
the  superfusing  Ringers is the %  IK- 
[AChlss  =  (/K[ACh]  in  LTC4)/(control  I K- 
[ACh]ss)  X  100.  Data  are  plotted  as 
mean  -+  SEM  (except  for  70  p,M 
LTC4,  which  is  plotted  as  the 
average -+ range  for  n  =  2).  The 
number  of  independent  determina- 
tions is indicated in parentheses. Data 
were fitted by nonlinear least-squares 
minimization  to  the  following equa- 
tion:  B  +  max/(1  + K/[LTC4]),  with 
best  fit  parameters  B  =  98.04%; 
max =  56.75%; K =  3.06 p,M. 
mediated IK[ACh] activation rate suggest that the primary role for LTC4 under these 
experimental  conditions  (i.e.,  in  the  presence  of  GTPTS)  is  promotion  of  Gk 
activation. 
LTC4 Modulation  of GTPyS-mediated Activation  of IK[AChl 
LTC4 (10  ~M) increases the rate of GTP~/S-mediated activation of IK[ACh~ in both the 
absence and presence of ACh  (Scherer and Breitwieser,  1990).  To establish whether 
these  effects  are  mediated  by  LTC4  at  the  same  site  that  modulates  IK[ACh]ss, we 
determined the concentration dependence of the LTC4-mediated increases in IK[ACh] 
activation rates. 
Fig.  4A  illustrates  a  typical  experiment  used  to  measure  the  rate  of GTP~/S- 
mediated IK[ACh] activation in  the  presence  of LTC4.  Pipette  solutions contained  1 
mM GTP~/S. Immediately upon achieving the whole-cell configuration, 70  ~M LTC4 
was added to the bath solution until a linear rate of IK[ACh] activation was observed.  1 
~M ACh was then superfused to fully activate IK[ACh] (note that the ACh solution did 
not  contain  LTC4).  The  linear,  initial  rate  of IK[ACh] activation was  normalized  to 
IK[ACh]ss determined  in  the  absence  of  LTC4  (i.e.,  the  control,  GTP~/S-mediated 
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GTPTS-activated  /K[ACh]ss- Pipette con- 
tained 1 mM GTPTS.  1 IJLM ACh was 
applied briefly (10 s) to fully activate 
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FIGURE 4.  Effect  of LTC4  on  basal 
and  ACh-dependent  GTP~/S-medi- 
ated rates of/K[ACh] activation. Pipette 
solutions contained  1 mM GTP~S and 
0.05 mM GTP (20: l  ratio).  (A) Effect 
of LTC4 (70 o,M) on the basal rate of 
IK[ACh] activation.  Immediately  upon 
patch  rupture,  the  superfusing  solu- 
tion was  switched from control  Ring- 
ers  to  one  containing  70  I~M  LTC4. 
After  an  observable  initial  rate  was 
obtained,  the  superfusing  solution 
was switched to one containing  1 o,M 
ACh (but no LTC4). Washout  of ACh 
resulted  in  a  stable  GTP~/S-activated 
/K[AChlss.  (B)  Concentration  depen- 
dence  of LTC4  enhancement  of the 
GTP'yS-mediated  /K[ACh]  activation 
rate.  Experimental  protocol  illus- 
trated  in A. The  LTC4 concentration 
is plotted  versus  the normalized  rate 
OflK[ACh] activation (min-l), calculated 
as:  initial rate (pA/min)/IK[ACHss  (pA). 
Data  were  fitted  (solid  line)  to  the 
equation: B  +  max/[l +  (K/[LTC4])"], 
with  B  =  0.28  min-l;  max  =  0.353 
min-*;  K  =  4.74  p,M;  n  =  1.4.  (C) 
Concentration  dependence  of  LTC4 
enhancement of the GTP-/S-mediated 
IK[ACh] activation rate  in the presence 
of 1 nM ACh.  Experimental protocol 
as  in A,  with  both  LTC4  and  1  nM 
ACh in the superfusing solution. Data 
were  fitted  (solid  line)  with  the  same 
equation  as  in  B,  with  B  =  0.83 
min-~; max  =  1.44  min-l; K  =  4.88 
o,M; n  =  2.3.  Data plotted  in both B 
and C represent mean _+ SEM, with at 
least  four  independent  experiments 
at each concentration of LTC4. Dashed 
lines  in  both  B  and  C  are  the  relationships  obtained  when  the  rate  of IK[ACh] activation  is 
calculated by normalization to the LTC4-enhanced IK[ACh]ss (obtained by multiplying/K[ACh]ss  in 
each experiment by the fold increase in lKIACh]ss produced by that dose of LTC4, calculated from 
the fit in Fig. 2). 
/K[ACh]ss).  The  LTC4  dose  response  for  the  basal,  mAChR-independent,  GTP-yS- 
mediated  rate  of/K[ACh] activation is illustrated  in Fig. 4  B. The  data were fitted with 
the Hill equation, with a  K0.5 of 4.7  ~M and  a  Hill coefficient of 1.4. 
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illustrated  in  Fig.  4 C.  Experiments were  as  in  Fig.  4A,  except that  the  cell was 
exposed to a solution containing both the test concentration of LTC4 and 1 nM ACh. 
The  rate  of IK[ACh] activation in  the  absence  of LTC4 under  these  conditions was 
0.76  ±  0.03  rain-1  (n =  5),  which  is  consistent with  the  enhanced  rate  of IK[AChl 
activation mediated by I nM ACh (Breitwieser and Szabo, 1988). The data of Fig. 4 C 
were fitted with the Hill equation, with a K0.5 of 4.9 p,M and a Hill coefficient of 2.3. 
The  similarities  in  the  estimated /(o.5 for LTC4 mediation  of both  the  increase  in 
GTP~S-activated IK[ACh]ss (Fig. 2) and for enhanced GTP~/S-mediated IKtACh] activation 
rates  (in  the  absence  [Fig.  4B]  and  presence of 1 nM ACh  [Fig.  4 C])  suggest  a 
common site of LTC4 action. 
The  GTP~/S-mediated rate  of IK[ACh] activation is  normalized  to  the  steady-state 
IK[ACh3 obtained  in  each cell,  which  has  been  considered  to  reflect the  rate  of Gk 
activation  (Breitwieser  and  Szabo,  1988).  The  rates  of  GTP~/S-mediated  IK[AChl 
activation in the presence of LTC4 were also determined in this manner (Fig. 4). This 
is an overestimate of the effect of LTC4 on the rate of Gk activation, however, since 
LTC4 can increase the steady-state GTP~/S-activated [K[ACh] (Fig. 2) independent of an 
effect on Gk activation (i.e., when all of Gk has been persistently activated by GTP~S). 
The two effects of LTC4 (i.e., on Gk activation and on steady-state GTP~/S-activated 
[K[ACh]) can be separated,  however, since  (a)  the  effect of LTC4 on IK[ACh]ss can be 
independently  determined  (Fig.  2);  (b)  the  effect  of LTC4  on  IKtACh]~ is  rapidly 
reversible (Fig.  1,  B  and  C);  and  finally,  (c) I~[AChlss determined in  the  absence of 
exogenous LTC4 is not a function of continued, endogenous LTC4 production (Fig. 
3).  Plotted as dashed lines in  Fig.  4, B  and C,  are the dose-response relationships 
obtained  by  normalizing  to  the  LTC4-modulated  IK[ACh]ss (calculated  from  the 
dose-response relationship in Fig. 2). Estimated in this manner, the LTC4-mediated 
increases in IK[AChJss and in Gk activation rate each account for ~ 50% of the effect of 
LTC4 on the rates of GTP~/S-mediated IK[ACh] activation. 
Effects of LTC4 on Gk Activation Rates 
Gk activation incorporates a number of kinetically distinct steps, including release of 
GDP, binding  of GTP (or GTP~/S),  dissociation into a  guanine  nucleotide triphos- 
phate-bound ~Xk plus  [3~/, and diffusion of activated subunits  to the  I~Ach] channel. 
Any or all of these steps may be modulated by LTC4. We had previously assumed that 
the limiting rate of IK[ACh] activation was due to the slow,  basal rate of GDP release 
from the inactive heterotrimeric Gk (Breitwieser and Szabo,  1988), but it is possible 
that this step is not rate limiting under all conditions. LTC4 might affect the rate of 
GTP~/S-mediated IK~ACh] activation not by modulating the rate of GDP release, but by 
altering  the  relative GTP',/S/GTP affinities of the  nucleotide-free form of Gk,  i.e., 
increasing the affinity of Gk for GTP~S relative to GTP. To assess this possibility, we 
determined the effect of 3 ~M LTC4 on the rates of IK~ACh] activation in the presence 
of various GTP~/S/GTP concentration ratios. The rates of activation in the presence 
of LTC4 were determined as illustrated in Fig. 4 A, normalized to IK~ACh1~ measured 
in the absence of LTC4. The GTP~/S/GTP dose-response relationships are illustrated 
in Fig. 5. The GTP~/S/GTP ratio that mediates the half-maximal IK~ACh] activation rate 
is  1.5  in both the presence and absence of 3  ~M  LTC4, suggesting that LTC4 does 
not alter the relative affinities of Gk for GTP and GTP~/S. Although it is possible that SCHERER ET AL.  Leukotriene C, Modulation of Muscarinic K ÷ Current Activation  133 
LTC4 may alter the diffusion of subunits to the channel, this possibility seems unlikely 
since lipid analogues such as LTB4 and LTD4 did not mimic the effect, although they 
might be expected  to produce comparable changes in membrane fluidity. Thus the 
most likely steps for LTC4 modulation of Gk activation rates are (a) the rate of GDP 
release  or  (b)  the  rate  of  dissociation  of  Gk  subunits,  once  guanine  nucleotide 
triphosphate  has bound. These two steps  are not distinguishable  under our experi- 
mental  conditions,  and we thus  lump  them  together  into  the  term  "Gk activation," 
which is clearly modulated by LTC4. 
LTC4 Modulation of GTP-mediated Activation of Ir4AChl 
The results of the previous sections suggest that LTC4 both enhances the rate of Gk 
activation  and  increases  GTP~/S-activated  IKtACh]ss. It is  likely,  therefore,  that  GTP- 
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FIGURE 5.  Effect of LTC4 on depen- 
dence  of  /K[ACh] activation  rate  on 
GTP-yS/GTP concentration ratio.  Ex- 
periments  as  illustrated  in  Fig.  1 A 
were  performed  with  different 
GTPTS/GTP  concentration  ratios  in 
the  absence  (filled  circles) and  pres- 
ence (open circles) of 3 v.M LTC4. The 
normalized  rate  of IKiACh] activation 
(normalized  in  both  cases  to  the 
lv4AChjss in  the  absence  of  LTC4)  is 
plotted versus the [GTP,/S]/[GTP] ra- 
tio. Data points represent the mean -+ 
SEM  for  at  least  four  independent 
experiments  at  each  [GTP,/S]/[GTP] 
ratio. Actual concentrations were: 20:1, 1 mM GTP~S/50 I~M GTP; 5:1, 1 mM GTP~/S/200  IxM 
GTP;  3.5:1,  368  i~M  GTP~/S/105  v~M GTP; 2:1,  100  p.M  GTP~/S/50  wM GTP;  1:1,  50  p.M 
GTP',/S/50 v,M GTP. Data for both curves were fitted to the equation: max/{1 +  [K/([GTP~IS]/ 
[GTP])]"}. Best fit parameters were: (control) max =  0.3 rain -1, K =  1.48 v.M, n  =  1.43; (3 v,M 
LTC4) max =  0.46 rain -I, K =  1.45  v.M, n  =  1.6. 
dependent  IKtACh] activation  should  likewise  be  enhanced.  We  examined  both  the 
effects of exogenously applied  LTC4 and blockers  of endogenous LTC4 production 
on the activation of IK[ACh]  by ACh in the presence of intracellular  GTP. 
A double ACh application protocol was developed to allow each cell to serve as its 
own control, as illustrated  in Fig. 6A. ACh (1  IxM) was applied for 2 rain, followed by 
a return to control Ringers solution for at least 4 rain.  1 vLM ACh was then applied a 
second time in the absence (Fig. 6 A ) or presence of various modulators (Fig. 6, B-F). 
In the control experiment (Fig. 6 A ) both peak IKtACh]  and IK[ACh]ss  (assessed 90 s after 
the  peak)  of the  second  application  of ACh were  indistinguishable  from  the  first 
([peak2/peakl]%:  99.8 -+ 1.3%;  [SS2/SSI]%:  97.3 -+ 2.7%;  n  --- 6),  confirming  that  a 
4-rain  control  period  between  ACh  applications  was  sufficient  to  allow  complete 
recovery from desensitization. 134  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  102  •  1993 
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FIGURE 6.  Effect of LTC  4 on ACh-dependent IK[AChl  activation. Two applications of 1 p,M ACh 
(separated by a 4-5-min wash period in control Ringers solution) were applied to each cell, to 
allow each cell to  serve as its own  control. The  second ACh  exposure was accompanied by 
various test compounds.  (A) Control experiment, demonstrating that the 5-min wash period 
between ACh applications is sufficient to fully restore both peak/K[ACh]  and IK[ACh]ss.  (B) Effect of 
10 p~M LTC4. The second application of ACh was accompanied by 10 p,M LTC4.  (C) Effect of 
10  p,M  ETYA.  10  p,M  ETYA  was  superfused  1  min  before  and  during  the  second  ACh 
application. (D) LTC4 can eliminate the block of 1K[ACh]  produced by ETYA.  10 ~M ETYA was 
superfused 1 min before and during the second ACh application, which was accompanied by 10 
p,M LTC4.  (E) Effect of 5  p,M L-655,238.  5  I~M L-655,238 was superfused 2 rain before and 
during the  second  I-p,M ACh application. (F) LTC4  can eliminate the block of peak 1K[AOa] 
produced by L-655,238.5  ~M L-655,238 was superfused 1 min before and during application 
of both 1 p,M ACh and  10 ~M LTC4. 
When  10 ~M LTC4 is applied coincident with the second ACh challenge, there is a 
significant increase in the instantaneous peak IK[ACh]: [peak2(LTC4)/peakl(control)]%: 
122  +  6.7% (n =  5). There is greater variability in the steady-state IK[ACh] activated in 
the presence of ACh plus  10  I~M LTC4 when compared with that activated by  1 I~M 
ACh alone: [SS2(LTC4)/SS1(control)]% is 114  -+ 22% (n =  5), but there appears to be 
a  slight stimulatory effect of 10  p,M LTC4. SCHERER ET AL.  Leukotriene  C4 Modulation of Muscarinic  K + Current Activation  135 
Since exogenously applied LTC4 enhances peak IKEAChl  activated in the presence of 
ACh, we determined whether endogenous LTC4 production might be responsible for 
activation of peak IKEAChi  under control conditions. The ability of ACh to elicit IKEACh] 
in  the  presence  of 10  p-M  ETYA (which blocks  endogenous production of leuko- 
trienes from free arachidonic acid) or 5 p-M L-655,238 (which prevents activation of 
5-1ipoxygenase activating protein  [Evans et al.,  1991])  was  examined. The results, 
illustrated in Fig.  6,  C and E,  suggest that block of endogenous LTC4 production 
severely limits the ability of ACh to activate IK[ACh]. In the presence of either 10 p-M 
ETYA or 5 p-M L-655,238, ACh is able to activate IK[ACh], albeit without activation of 
an instantaneous peak IKEACh]  and with a greatly attenuated IK[AChlss. ETYA (at 10 IzM) 
produces a slowing of the rate of IgEhChl activation by ACh, while low concentrations 
of L-655,238 (3-5 p.M) block activation of peak IKEACh]  without an effect on the initial 
rate of IK[AChl activation. High concentrations of L-655,238  (10-20  p-M) mimic the 
effects  of  ETYA,  both  blocking  peak  IKfACh~ activation  and  slowing  the  rate  of 
activation in response to 1 IxM ACh. 
Both  ETYA and/or  L-655,238  may cause  block  of peak  IK[ACh] activation by  a 
variety of potential mechanisms: (a) direct block of the K~AChl  channel; (b) nonspecific 
perturbations of the myocyte membrane which interferes with signal transduction; or 
(c) block of LTC4 synthesis. Direct block of the KIACh  j channel does not occur, since 
neither  ETYA  (Fig.  4)  nor  L-655,238  (data  not  shown)  blocks  GTP~/S-activated 
IKIAChlss"  Nonspecific perturbations of the myocyte membrane that affect the mAChR- 
mediated signal transduction pathway can be ruled out by determining whether the 
effects of ETYA and/or L-655,238 are mitigated by exogenously applied LTC4. When 
the second application of ACh includes both ETYA and LTC4 (Fig. 6 D) or L-655,238 
and LTC4 (Fig. 6 F), the time course and magnitude OflKtACh]  resembles the response 
in the presence of ACh plus LTC4 (Fig. 6 B ), suggesting that the effects of ETYA and 
L-655,238 can be attributed to block of endogenous LTC4 production. 
Other  inhibitors  of  LTC4  synthesis,  including  CDC  and  baicalein,  also  block 
activation of peak IKIAChl  in response to application of 1 p-M ACh by the double pulse 
protocol illustrated in Fig. 6. All of these compounds inhibit activation of peak IKIAChl, 
with more variable effects on steady-state IKIACh] (60--90  S after peak), as illustrated in 
Table I. The commonality of the effects with a variety of LTC4 synthesis inhibitors 
strongly  supports  a  role  of endogenous  arachidonic  acid  metabolites,  specifically 
LTC4, in activation of peak IKtACh]. 
DISCUSSION 
LTC4 Modulation of IK[AChI Activation 
We have used a variety of experimental strategies to investigate the role of LTC4 in 
modulating activation of the muscarinic K + channel of bullfrog atrial myocytes. We 
find that LTC4 enhances GTP,/S-mediated IK[ACh] activation by increasing both the 
apparent rate  of Gk activation (either GDP  release  from Gk or dissociation of the 
activated  Gk  complex  into  ct  GTP  and  13~  subunits)  and  the  ability  of  activated 
G  ,  GTP and/or 133' subunits) to activate the K[ACh  I channel. LTC4 does not alter the  k ~0L  k 
relative affinities of Gk for GTP and GTP~/S. All of the  effects of LTC4 on IK[ACh] 
activation are  produced with a  K0.5 of 3-5  ~M,  and we  hypothesize that they are 136  THE JOURNAL OF GENERAL PHYSIOLOGY • VOLUME 102  • 1993 
mediated by LTC4 binding to a common site. Kinetic cooperativity is apparent in the 
enhancement of the rate of GTP~/S-mediated IK[AChl activation, presumably since both 
LTC4-mediated  increases  in  Gk  activation  rate  and  Gk-mediated  activation  of the 
K[ACh  I channel  (as assessed by LTC4-mediated increases in GTP~/S-activated IK[ACh]ss) 
contribute to the overall rate of IK[ACh] activation. Block of cellular LTC4 biosynthesis 
with a variety of inhibitors of either 5-1ipoxygenase (ETYA, CDC, baicalein) or FLAP 
(L-655,238)  results in a  greatly attenuated response to ACh under control (intracel- 
lular  GTP)  conditions,  i.e.,  absence  of peak  and  decreased  IK[ACh]ss- Exogenously 
applied LTC4  can  restore  normal responsiveness  to ACh  in  the  presence  of LTC4 
biosynthesis inhibitors,  suggesting that  the  inhibitors are affecting IK[ACh] activation 
by reducing the cellular availability of LTC4. 
TABLE  I 
Effect of Various Inhibitors of LTC4 Synthesis on the Activation of Peak 
and Steady-State lrtAchl 
Compound  (Peak2/peakl)%  (SS2/SSI)% 
10 p.M ETYA  53 -+ 6.6 (4)  77.5 + 5.9 (4) 
3 p.M L-655, 238  47 -+ 2.4 (4)  94 -  3 (4) 
5 p.M L-655, 238  40 -+ 3.2 (4)  82 -+ 3 (4) 
10 p.M CDC  57 -+ 7 (5)  83 -+ 7 (5) 
10 p.M baicalein  51 + 5.2 (6)  75 -+ 4.4 (6) 
The  double  ACh  application  protocol  was  used  (as  illustrated  in  Fig.  6).  The 
compounds indicated in the table were present during the second application of 1 I~M 
ACh. For those compounds that inhibit activation of peak current, peak~ is defined as 
the maximum activatable IKtAChI"  (Peak~/peakl)% is defined as the ratio of the peak 
IK[AChl produced in response  to  1 p.M ACh plus  the compound  of interest  to  the 
control peak IKIAChl  in response to 1 p.M ACh in the same cell x  100. (SSz/SS0%  is the 
ratio of the steady state (60-90 s after the peak) of IK[AChl  in the presence of 1 p.M ACh 
plus the compound of interest to that observed under control conditions in the same 
cell x  100. 
Characterization  of LTC4 Receptors in Atrial Myocytes 
Leukotriene receptors have been identified in a  variety of tissues, and appear to fall 
into  two  distinct signaling classes  (Piper,  1984;  Crooke,  Mong,  Clark,  Hogaboom, 
Lewis,  and  Gleason,  1987;  Cristol,  Provencal,  and  Sirios,  1989).  LTB4  and 
LTD4(LTE4)  receptors  have  been  well characterized,  and  are  coupled  to  cell  pro- 
cesses by G  proteins. Activation of LTB4 or LTD4(LTE4) receptors results in increases 
in  intracellular Ca  2+,  IP3,  and  activation of protein kinase C  (Saussy, Sarau,  Foley, 
Mong,  and  Crooke,  1989;  Snyder  and  Fleisch,  1989;  Bouchelouche  and  Berild, 
1991).  In contrast, biological effects of LTC4 have been identified in numerous  cell 
types,  including  modulation  of leutinizing  hormone  secretion  (Hulting,  Lindgren, 
Hokfelt, Eneroth, Werner, Patrono, and Samuelsson,  1985;  Kiesel, Przylipiak, Habe- 
nicht,  Przylipiak, and  Runnebaum,  1991;  Dan-Cohen,  Sofer,  Schwartzman,  Natara- 
jan,  Nadler,  and  Naor,  1992)  and  cardiac  contractility  (Hattori  and  Levi,  1984; 
Herman,  Heller,  Canavan,  and  Herman,  1988;  Robleto,  Reitmeyer,  and  Herman, 
1988;  Herman,  Heller,  and  Herman,  1990),  and  activation  of  Ca  z+  channels  in SCHERER Err AL.  Leukotriene C4 Modulation  of Muscarinic  K + Current Activation  137 
response to epidermal growth factor (Peppelenbosch, Tertoolen, den Hertog, and de 
Laat,  1992),  although little is  known about  the  signal transduction mechanism(s). 
Activation of cardiac LTC4 receptors  causes changes  in cardiac contractility under 
conditions in which conversion of LTC4 to LTD4(LTE4)  is prevented and alterations 
in cell Ca  2+ or IP3 are not observed (Herman et al.,  1988;  Chiono, Heller, Andazola, 
and Herman,  1991).  LTC4 binding is not affected by GTP (Hogaboom, Mong, Wu, 
and Crooke,  1983;  Mong, Wu, Scott, Lewis, Clark, Weichman, Kinzig, Gleason, and 
Crooke,  1985;  Cristol et al.,  1989),  suggesting that the receptor does not belong to 
the G protein-coupled superfamily. 
Binding  sites  for  LTC4 are  widely distributed  (Cristol  et  al.,  1989),  although a 
biological  activity  associated  with  LTC4  binding  is  not  always  apparent.  Careful 
analysis of LTC4 binding sites suggests that some apparent  LTC4 "receptors" may 
represent  cytoplasmic enzymes such  as  glutathione  transferase  (Sun,  Chau,  Spur, 
Corey, Lewis, and Austen, 1986;  Sun, Chau, and Austen, 1987).  Recent characteriza- 
tions  of  LTC4  receptors  have  used  isolated  membranes  and  parallel  assays  for 
enzymatic binding  sites,  as  well  as  serine  borate  to  prevent  LTC4  metabolism  to 
LTD4(LTE4)  (Herman et al.,  1988;  Chiono et al.,  1991).  It remains clear that LTC4 
receptors represent a distinct class with potentially novel signaling mechanisms. 
Binding studies in membranes isolated from bullfrog ventricle (Chiono et al., 1991) 
indicated a  single class of LTC4 binding sites with Kd of 34  nM  and a  Bmax of 52 
pmol/mg protein  (in  the  presence  of 45  mM  L-serine borate),  with a  decrease  in 
affinity of two orders of magnitude in the absence of serine/borate. LTC4 binding was 
not antagonized by up to 10 p.M LTD4, 30 ~M LTE4, or GTP~S. Our data in bullfrog 
atrial  myocytes are  consistent with  the  characteristics  of LTC4 receptors  in  mem- 
branes  of bullfrog heart.  LTC4-mediated modulation of IK[ACh] activation does not 
involve a  G  protein-mediated  pathway, since  the  LTC4 effect is  rapidly reversible 
upon washout of the lipid, even in the presence of GTP'yS. Since our electrophysio- 
logical experiments were  performed  in  the  absence  of serine  borate,  the  Ko.5 for 
modulation OflK[AChl activation (3-4 ~M) is in line with that observed by Chiono et al. 
(1991).  In addition, neither LTB4 nor LTD  4 was able to mimic the effect of LTC4, 
suggesting that the responses are specifically initiated by activation of LTC4 recep- 
tors. 
Mechanism  of LTC4-mediated  IK[ACh  ] Modulation 
The  increasing  complexity of the  mechanism  of IK[ACh] activation, via  muscarinic 
(Breitwieser  and  Szabo,  1985;  Pfaffinger, Martin,  Hunter,  Nathanson,  and  Hille, 
1985),  cq-adrenergic (Kurachi et al.,  1989;  Braun, Fedida, and Giles,  1992),  adeno- 
sine (Kurachi, Nakajima, and Sugimoto, 1986),  platelet activating factor (Nakajima et 
al.,  1991;  Ramos-Franco,  Lo,  and  Breitwieser,  1993),  and  calcitonin gene-related 
peptide  (Kim,  1991)  receptors  suggests that multiple signal transduction pathways 
(and distinct identities of coupling G proteins) are possible. In addition, both Otk and 
[3"y subunits may play multiple roles in IK[ACh] activation (Breitwieser, 1991), including 
potential direct interaction with the  KIACh  I channel (Birnbaumer, Abramowitz, and 
Brown,  1990;  Birnbaumer,  1992;  Ito  et  al.,  1992),  activation  of phospholipases 
(Clapham,  1990),  and  potential participation  in  desensitization via  13~/ binding to 
f3-adrenergic receptor  kinase  or the  muscarinic receptor  kinase homologue (Haga 138  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  -  VOLUME  102  .  1993 
and  Haga,  1992;  Pitcher,  Inglese,  Higgins,  Arriza,  Casey,  Kim,  Benovic,  Kwatra, 
Caron,  and  Lefkowitz,  1992).  A  region  of the  ai  subunit  NH 2  terminus  has  been 
implicated in the interaction with 13~/, and may also be involved in modulation of the 
GDP  release  rate  during  G  protein  activation  (Osawa,  Khanasekaran,  Woon,  and 
Johnson,  1990;  Dhanasekaran,  Osawa,  and Johnson,  1991),  and thus the stability of 
the interaction between ak and [3~ is also a  potential site for modulation. 
The results of our experiments suggest that  some of the kinetic properties of the 
muscarinic  receptor-Gk-K[Achl channel  signal  transduction  pathway  are  altered  by 
LTC4 to produce enhanced activation of the K[ACh  ] channel. Furthermore, our results 
suggest  that  cellular biosynthesis of LTC4  may  contribute  to  the  process  of IK[ACh] 
activation;  i.e.,  LTC4  is  required  for  the  rapid,  ACh-mediated  activation  of IK[ACh] 
under  physiological  (GTP)  conditions,  but  is  not  required  for  maintenance  of 
steady-state/K[ACh] in the presence of either GTP or GTP~/S. 
The  mechanism(s)  by which  LTC4  mediates its effects on  Gk activation cannot be 
resolved from the present experiments, but it is possible that either C~k or [3~ or their 
interaction with each other or the K[ACh  ] channel may be altered by LTC4. We suggest 
that these latter participants in the signal transduction pathway are most likely to be 
affected,  since  the  response  to  LTC4  can  be  observed  in  the  absence  of mAChR 
stimulation, or after all of Gk has been persistently activated by GTP~S.  Since LTC4 
receptors  have  not  been well characterized  (and  no  selective antagonists  exist), we 
cannot  distinguish  between  direct  interaction  of LTC4  with  proteins  in  the  K[ACh  ] 
channel signal transduction pathway, or mediation of the effects by a  potential LTC4 
receptor and novel signal transduction mechanism. Further experiments are required 
to fully define the role(s) for arachidonic acid metabolites in the modulation oflK[ACh] 
activation, and the potential contributions of cellular lipid metabolism to regulation 
of other G  protein-dependent  processes. 
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